AURINIA PHARMACEUTICALS INC (AUPH)

CA05156V1022 - Common Stock

5.15  +0.06 (+1.18%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
175.51M134.00M45.60M50.10M300.00K
Cost Of Goods
14.15M5.70M1.10MN/AN/A
Gross Profit
161.37M128.40M44.50MN/AN/A
Operating Expenses
253.06M239.80M225.20M154.40M91.30M
Research and Development
49.64M45.00M51.10M50.30M52.90M
Selling, General, and Administrative Expenses
195.04M196.40M171.40M96.00M22.30M
Operating Income
-91.69M-111.50M-180.70M-104.30M-90.90M
Interest Income/Expense
14.22M5.10M500.00K1.50M2.70M
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-77.47M-106.40M-180.20M-102.80M-88.20M
Income Tax
551.00K1.80M800.00K-100.00K100.00K
Net Income
-78.02M-108.20M-181.00M-102.70M-88.40M
EBITDA
-80.04M-108.79M-177.94M-102.93M-89.73M
 
Per Share Data
EPS Diluted Total Ops
-0.54-0.76-1.40-0.87-0.95
Non GAAP EPS
-0.54-0.76-1.41-0.74-1.30
 
Statistics
Gross Profit Margin
91.94%95.82%97.59%N/AN/A
Profit Margin
-44.45%-80.75%-396.93%-204.99%-29466.67%
Operating Profit Margin
-52.24%-83.21%-396.27%-208.18%-30300.00%

All data in USD

Charts